High-Expression HBO1 Predicts Poor Prognosis in Gastric Cancer.
Where this comes from
- Record sourced from PubMed, PMID 31247063.
- Also identified by DOI 10.1093/ajcp/aqz065.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Our goal was to assess the expression of histone acetyltransferase binding to origin recognition complex 1 (HBO1) in gastric cancer and the effect on prognosis for the patients. We used quantitative reverse transcription polymerase chain reaction, Western blot, and tissue microarray immunohistochemistry to investigate the expressions of HBO1 messenger RNA (mRNA) and protein in gastric cancer tissues. Online resources, including Oncomine and Kaplan-Meier Plotter, were used to further assess the correlation between HBO1 expression and the prognosis of the patients with gastric cancer. HBO1 mRNA and protein expressions in gastric cancer tissues were both significantly higher than those in normal tissues. The correlations between high HBO1 expression and differentiation, invasive depth (T), lymph node metastasis (N), distant metastasis (M), TNM staging, and serum carcinoembryonic antigen levels were positive. High HBO1 expression was negatively correlated with survival time in patients with gastric cancer. HBO1 might be a valuable biomarker to evaluate the prognosis of patients with gastric cancer.
Medical subject headings
- Adenocarcinoma
- Gastric Mucosa
- Gene Expression Regulation, Neoplastic
- Histone Acetyltransferases
- Stomach
- Stomach Neoplasms